AstraZeneca PLC - Minority Interest Expense

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Minority-Interest-Expense" stands at 0.005 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

AstraZeneca PLC's third quarter result of 0.002 Billion USD for the item "Minority Interest Expense" represents an increase of 200.00 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 0.002 Billion USD for the item "Minority Interest Expense" represents a decrease of -50.00 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 0.005 Billion USD for the item "Minority Interest Expense" represents a decrease of -28.57 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.
The 1 year change is 0.0 Billion United States Dollars.
The 3 year change is 0.0 Billion United States Dollars.
The 5 year change is 5.76 Billion United States Dollars.
The 10 year change is 0.008 Billion United States Dollars.

The Serie's long term average value is -1.71 Billion United States Dollars. It's latest available value, on 09/30/2025, is 1.71 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +6.96 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -0.005 Billion.